Literature DB >> 3030763

The effect of chronic captopril therapy on platelet angiotensin II receptor density and vascular responsiveness to angiotensin II infusion.

G B Kondowe, J G Kelly, S Copeland, G D Johnston.   

Abstract

The density of angiotensin II (Ang II) receptors on the platelet and the vascular responsiveness to infused angiotensin II before and after two weeks of captopril therapy were examined in ten healthy male volunteers. There was a significant increase in blood flow to the forearm, but no significant changes in either the density of angiotensin II receptors or the pressor response to infused angiotensin II following captopril therapy. The study demonstrates that long term reduction of angiotensin II formation by captopril in man does not increase the responsiveness of the receptors to infused angiotensin, nor results in an "up regulation" of the angiotensin receptors. It also provides further evidence that some of the long term vasodilator effects of captopril may be mediated by mechanisms other than inhibition of angiotensin I (Ang I) converting enzyme.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030763     DOI: 10.1007/BF00606624

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  New approaches to the study of angiotensin tachyphylaxis.

Authors:  A F Moore; F M Bumpus; P A Khairallah
Journal:  Mayo Clin Proc       Date:  1977-07       Impact factor: 7.616

2.  Requirements for angiotensin tachyphylaxis in smooth muscles.

Authors:  T B Paiva; M E Miyamoto; L Juliano; A C Paiva
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Angiotensin receptors.

Authors:  S Y Lin; T L Goodfriend
Journal:  Am J Physiol       Date:  1970-05

5.  Endocrine profile in the long-term phase of converting-enzyme inhibition.

Authors:  S L Swartz; G H Williams; N K Hollenberg; F R Crantz; T J Moore; L Levine; A A Sasahara; R G Dluhy
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

6.  Attenuation of pressor responses to norepinephrine and pitressin and potentiation of pressor response to angiotensin II by captopril in human subjects.

Authors:  Y Imai; K Abe; M Seino; T Haruyama; J Tajima; M Sato; T Goto; M Hiwatari; Y Kasai; K Yoshinaga; H Sekino
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

7.  Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.

Authors:  C I Johnston; B H Clappison; W P Anderson; M Yasujima
Journal:  Am J Cardiol       Date:  1982-04-21       Impact factor: 2.778

8.  Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes.

Authors:  J Douglas; K J Catt
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Angiotensin II receptors on human platelets.

Authors:  T J Moore; G H Williams
Journal:  Circ Res       Date:  1982-09       Impact factor: 17.367

Review 10.  An overview of the clinical pharmacology of enalapril.

Authors:  R O Davies; H J Gomez; J D Irvin; J F Walker
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

View more
  1 in total

1.  A lack of effect of captopril on platelet aggregation in patients with congestive heart failure.

Authors:  I F Gow; A D Flapan; M Morris; E Davies; B C Williams; P L Padfield; T R Shaw; C R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.